PHARMACOTHERAPY OF NEUROPATHIC PAIN


如何引用文章

全文:

详细

Neuropathic pain (NP) is widespread in the population, and treatment of patients with NP is a significant medical problem. According to epidemiological studies in the Russian Federation and other countries, up to 80% of patients with NP receive irrational therapy. The article presents algorithms for treatment of NP in various neurological diseases in agreement with the European Federation of Neurological Societies guidelines 2010.

参考

  1. Боль. Руководство для врачей и студентов / Под редакцией Н.Н. Яхно. М., 2009. C. 304.
  2. Данилов А.Б., Давыдов О.С. Диагностика и фармакотерапия нейропатической боли // РМЖ. 2009. № 20. С. 1389-1394.
  3. Данилов А.Б., Давыдов О.С. Нейропатическая боль. М., 2007. C. 192.
  4. Романенко С.В., Костюк П.Г., Костюк Е.П. Перспективы применения препарата габагамма для лечения диабетических полинейропатий // Наука та інновації 2009. № 6. С. 64-9.
  5. Яхно Н.Н., Кукушкин М.Л., Давыдов О.С. и др. Результаты Российского эпидемиологического исследования распространенности невропатической боли, ее причин и характеристик в популяции амбулаторных больных, обратившихся к врачу-неврологу // Боль 2008. №3. С. 24-32.
  6. Яхно Н.Н., Кукушкин М.Л., Давыдов О.С. и др. Результаты Российского эпидемиологического исследования распространенности невропатической боли (EPIC Study). Лечение невропатической боли // Consilium Medicum 2008. № 2.
  7. Agrawal RP, Choudhary R, Sharma P, et al. Glyceryl trinitrate spray in the management of painful diabetic neuropathy: a randomized double blind placebo controlled cross-over study. Diabetes Res Clin Pract 2007;77:161-67.
  8. Attala N, Cruccua G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010;17:1113-23.
  9. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. // J Am Med Ass 1998;280:1831-36.
  10. Bouhassira D, Lanteri-Minet M, Attal N, et al. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 2008;136:380-87.
  11. Chandra K, Shafiq N, Pandhi P, et al. Gabapentin versus nortriptyline in post-herpetic neuralgia patients: a randomized, double-blind clinical trial-the GONIP Trial. Int J Clin Pharmacol Ther 2006;44:358-63.
  12. Gilron I, Baley JM, Tu D, et al. Nortriptyline and gabapentin, alone and in combination for neuropathic pain : a double-blind, randomised controlled crossover trial. Lancet 2009;374:1252-61.
  13. Gordh TE, Stubhaug A, Jensen TS, et al. Gabapentin in traumatic nerve injury pain: a randomized, double-blind, placebo-controlled, cross-over, multi-center study. Pain 2008;138:255-66.
  14. Kadiroglu AK, Sit D, Kayabasi H, et al. The effect of venlafaxine HCl on painful peripheral diabetic neuropathy in patients with type 2 diabetes mellitus. J Diabetes Complications 2008;22:241-45.
  15. Kajdasz DK, Iyengar S, Desaiah D, et al. Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies. Clin Ther 2007;29:2536-46.
  16. Klit H, Finnerup NB, Jensen TS. Central post-stroke pain: clinical characteristics, pathophysiology, and management. Lancet Neurol 2009;9:857-68.
  17. Rintala DH, Holmes SA, Courtade D, et al. Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury. Arch Phys Med Rehab 2007;88:1547-60.
  18. Rowbotham MC, RachelDuan W, Thomas J, et al. A randomized, double-blind, placebocontrolled trial evaluating the efficacy and safety of ABT-594 in patients with diabetic peripheral neuropathic pain. Pain 2009;146:245-52.
  19. Rowbotham MC, Reisner LA, Davies PS, et al. Treatment response in antidepressant-naive postherpetic neuralgia patients: double-blind, randomized trial. J Pain 2005;6:741-46.
  20. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev 2007;4:CD005454.
  21. Shackelford S, Rauck R, Quessy S, et al. A randomized, double-blind, placebo controlled trial of a selective COX2 inhibitor GW406381 in patients with postherpetic neuralgia. J Pain 2009;10:654-60.
  22. Skljarevski V, Desaiah D, Zhang Q, et al. Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain. Diab Met Res Rev 2009;25:623-31.
  23. Torrance N, Smith BH, Bennett MI, et al. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain 2006;7:281-89.
  24. Wiffen P, McQuay H, Edwards J, et al. Gabapentin for acute and chronic pain. Cochrane Database Syst Rev 2005;20:CD005452.
  25. Wu CL, Agarwal S, Tella PK, et al. Morphine versus mexiletine for treatment of postamputation pain: a randomized, placebo-controlled, crossover trial. Anesthesiology 2008;109:289-96.
  26. Yuan RY, Sheu JJ, Yu JM, et al. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial. Neurology 2009;72:1473-78.

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##